Royal Bank of Canada’s ImmuCell ICCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1
Closed 7361
2025
Q3
$0 Buy
+1
New +$6 ﹤0.01% 7294
2024
Q3
Sell
-123
Closed -$1K 7102
2024
Q2
$1K Buy
123
+65
+112% +$313 ﹤0.01% 6827
2024
Q1
$0 Sell
58
-150
-72% -$773 ﹤0.01% 7256
2023
Q4
$1K Buy
208
+181
+670% +$883 ﹤0.01% 6935
2023
Q3
$0 Sell
27
-214
-89% -$1.09K ﹤0.01% 7296
2023
Q2
$1K Buy
+241
New +$1.23K ﹤0.01% 7012
2020
Q4
Sell
-88
Closed 7161
2020
Q3
$0 Buy
+88
New +$488 ﹤0.01% 6753
2020
Q1
Sell
-1
Closed 6818
2019
Q4
$0 Buy
+1
New +$5 ﹤0.01% 6941
2019
Q2
Sell
-1
Closed 6997
2019
Q1
$0 Hold
1
﹤0.01% 6930
2018
Q4
$0 Hold
1
﹤0.01% 6908
2018
Q3
$0 Hold
1
﹤0.01% 6811
2018
Q2
$0 Hold
1
﹤0.01% 6630
2018
Q1
$0 Hold
1
﹤0.01% 6538
2017
Q4
$0 Sell
1
-500
-100% -$4.09K ﹤0.01% 6690
2017
Q3
$3K Buy
501
+1
+0.2% +$7 ﹤0.01% 6514
2017
Q2
$4K Hold
500
﹤0.01% 6111
2017
Q1
$3K Hold
500
﹤0.01% 6350
2016
Q4
$3K Hold
500
﹤0.01% 6415
2016
Q3
$4K Sell
500
-500
-50% -$3.64K ﹤0.01% 6028
2016
Q2
$7K Hold
1,000
﹤0.01% 5847
2016
Q1
$7K Buy
+1,000
New +$6.67K ﹤0.01% 5839

Other funds holding ICCC

Royal Bank of Canada's ICCC Position: Q4 2025 in Review

Royal Bank of Canada sold out of ImmuCell (ICCC) in Q4 2025, closing a stake of 1 share.

Royal Bank of Canada first reported a position in ICCC in Q1 2016 and held it in 21 quarters. The position peaked at $7K in Q2 2016. 26 funds tracked by Wall St. Rank hold ICCC as of Q4 2025.

  • Royal Bank of Canada reported no remaining ImmuCell position as of Q4 2025 after selling out during the quarter.
  • Royal Bank of Canada sold 1 ImmuCell share in Q4 2025.
  • Royal Bank of Canada first reported a position in ImmuCell in Q1 2016 and held it in 21 quarters.
  • Royal Bank of Canada's ImmuCell position peaked at $7K in Q2 2016.
  • 26 funds tracked by Wall St. Rank held ImmuCell as of Q4 2025.

Based on Royal Bank of Canada's 13F filing for Q4 2025, filed 17 Feb 2026.